Rhinophyma Treated with Fractional CO2 Laser Resurfacing in a Woman of Color
JDD authors Samuel S. Kassirer BA, Robert H. Gotkin MD, and Deborah S. Sarnoff MD present the first reported case of rhinophyma in a 62-year-old Fitzpatrick V female patient who was successfully treated with one session of fractional CO2 laser resurfacing. This case highlights the successful use of the fractional CO2 laser to treat rhinophyma in darker skin types (Fitzpatrick IV–VI) and undersco …
Energy-Based Devices and Injectables: How to Combine them Safely & Effectively
ENERGY-BASED DEVICES & INJECTABLESAs Dermatologists, we have a number of tools at hand to help patients achieve their aesthetic goals, and it is more often than not the proper combination of these treatments that distinguish Dermatologists from other providers in the cosmetic space. At the recent 2021 ODAC Dermatology, Aesthetic and Surgical Conference, board-certified and cosmetically-trained dermatologist Dr. Jeremy Green from …
ENERGY-BASED DEVICES & INJECTABLES
Special Focus on Acne and Rosacea
Acne and RosaceaThe June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …
Acne and Rosacea
From Port-Wine Stain Treatments to Bovine Colostrum, Telomeres, and Skin Aging
Port-Wine StainThe May issue of the Journal of Drugs in Dermatology features dermatology articles on topics ranging from treatment updates on Port-Wine stain to the protective effect that liposomal bovine colostrum exerts on skin aging using telomere length as an aging biomarker. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Authors analyze extrusion forces of various produ …
Port-Wine Stain
Prescribing Isotretinoin for Transgender Patients
isotretinoin for transgender patientsCase Scenario A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren …
isotretinoin for transgender patients
error

Enjoy this blog? Please spread the word :)